FH Europe News

Join our Board of Trustees

Join our Board of Trustees

FH Europe is a young yet very successful, energetic and ambitious Patient Network. We represent 24, soon to be 25, patient organizations across the whole of Europe and are still growing. As a Network, we are actively working together to secure early identification and...

FH Europe joins the World Heart Federation and EURORDIS

FH Europe joins the World Heart Federation and EURORDIS

We are pleased to announce very positive and important updates. On April 17, 2020, FH Europe had been welcomed as an official member to the World Heart Federation - powerful global community of organizations dedicated to the treatment, prevention and control of...

Support for the FH Europe Network in COVID19 crisis

Support for the FH Europe Network in COVID19 crisis

Coronavirus, or COVID-19, has been declared a pandemic by the World Health Organisation. But what does this mean for those living with cholesterol or lipid conditions? In response to this unprecedented health crisis, FH Europe decided to host biweekly virtual meetings...

Rare disease day campaign 2020

Rare disease day campaign 2020

Raising awareness of homozygous Familial Hypercholesterolaemia (HoFH) and Familial Chylomicronemia Syndrome (FCS) Saturday, 29 February, was the 13th edition of Rare Disease Day. The campaign continues to grow each year since it was first launched in 2008 by EURORDIS....

Publication of FH Global Call to Action

Publication of FH Global Call to Action

FH Europe, the European FH Patient Network, and the European Atherosclerosis Society (EAS) collaborate with global stakeholders to tackle the global burden of Familial Hypercholesterolaemia (FH) FH Europe and the EAS announced today the publication of a Global Call to...

Archived News

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt
Site by: Vovi Web Design